#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	13936	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2065	670.4	1	SNP	n	C1184T	0	.	.	1184	1184	C	1433	1433	C	815	C	757	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24754	23S	2890	2890	99.9	23S.l15.c17.ctg.1	3455	713.7	0	.	n	.	0	T695C	SNP	695	695	T	952	952	C	751	C	700	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24754	23S	2890	2890	99.9	23S.l15.c17.ctg.1	3455	713.7	0	.	n	.	0	G1337A	SNP	1337	1337	G	1594	1594	A	909	A	847	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24754	23S	2890	2890	99.9	23S.l15.c17.ctg.1	3455	713.7	0	.	n	.	0	T1971C	SNP	1971	1971	T	2228	2228	C	849	C	778	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24754	23S	2890	2890	99.9	23S.l15.c17.ctg.1	3455	713.7	1	SNP	n	A2045G	0	.	.	2045	2045	A	2302	2302	A	818	A	775	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24754	23S	2890	2890	99.9	23S.l15.c17.ctg.1	3455	713.7	1	SNP	n	C2597T	0	.	.	2597	2597	C	2854	2854	C	819	C,A	753,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	1874	folP	855	855	100.0	folP.l15.c30.ctg.1	1565	119.4	1	SNP	p	R229S	1	.	.	685	687	AGC	1035	1037	AGC	190;188;189	A;G;C,A	178;176;172,1	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5062	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3480	145.2	1	SNP	p	S91F	1	.	.	271	273	TTC	595	597	TTC	171;171;170	T;T;C	163;163;162	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5062	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3480	145.2	1	SNP	p	G95N	0	.	.	283	285	GGC	607	609	GGC	159;158;159	G;G;C	152;152;151	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5062	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3480	145.2	1	SNP	p	D95G	1	.	.	283	285	GGC	607	609	GGC	159;158;159	G;G;C	152;152;151	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	1568	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1374	113.8	1	SNP	p	G45D	0	.	.	133	135	GGC	529	531	GGC	189;191;191	G;G;C	175;176;176	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	772	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1005	76.3	0	.	n	.	0	A197.	DEL	197	197	A	544	544	A	201	A	185	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5102	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2928	173.8	1	SNP	p	D86N	0	.	.	256	258	GAC	512	514	GAC	189;190;191	G;A;C	176;169;179	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5102	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2928	173.8	1	SNP	p	R87W	0	.	.	259	261	CGT	515	517	CGT	192;192;193	C;G;T	178;178;177	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5102	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2928	173.8	1	SNP	p	S87R	1	.	.	259	261	CGT	515	517	CGT	192;192;193	C;G;T	178;178;177	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5102	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2928	173.8	1	SNP	p	R87I	0	.	.	259	261	CGT	515	517	CGT	192;192;193	C;G;T	178;178;177	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5102	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2928	173.8	1	SNP	p	S88P	0	.	.	262	264	TCC	518	520	TCC	189;188;188	T;C;C	178;176;177	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4128	parE	1986	1986	100.0	parE.l15.c17.ctg.1	2415	169.2	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1435	1437	GGC	229;224;224	G;G;C	208;201;199	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	3686	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2314	158.5	1	SNP	p	A311V	0	.	.	931	933	GCA	1196	1198	GCA	205;204;203	G;C;A	191;190;193	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3686	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2314	158.5	1	SNP	p	I312M	0	.	.	934	936	ATC	1199	1201	ATC	202;201;204	A;T;C	191;186;190	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3686	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2314	158.5	1	SNP	p	V316T	0	.	.	946	948	GTG	1211	1213	GTG	201;200;198	G;T;G	189;185;184	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3686	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2314	158.5	1	SNP	p	V316P	0	.	.	946	948	GTG	1211	1213	GTG	201;200;198	G;T;G	189;185;184	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3686	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2314	158.5	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1715	1717	ACC	217;215;215	A;C;C	194;200;198	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3686	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2314	158.5	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1769	1771	GCG	199;194;195	G;C,T;G	174;154,1;162	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3686	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2314	158.5	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1769	1771	GCG	199;194;195	G;C,T;G	174;154,1;162	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3686	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2314	158.5	1	SNP	p	G543S	1	.	.	1627	1629	AGC	1892	1894	AGC	170;170;169	A,G;G;C	158,1;162;158	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3686	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2314	158.5	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1901	1903	GGC	160;160;160	G;G;C	151;149;147	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3686	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2314	158.5	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1919	1921	CCG	142;144;149	C,G;C;G	106,3;109;111	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5202	ponA	2397	2397	100.0	ponA.l15.c30.ctg.1	3237	160.3	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1685	1687	CCG	194;197;200	C,T;C;G	176,1;185;184	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2102	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1761	118.9	0	.	p	.	0	M83fs	FSHIFT	247	247	A	567	567	C	161	C	144	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	414	porB1a	984	273	91.58	porB1a.l15.c30.ctg.2	452	44.2	0	.	p	.	0	T250S	NONSYN	748	750	ACC	87	89	AGC	66;66;66	A;G,C;C	58;57,1;58	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	414	porB1a	984	273	91.58	porB1a.l15.c30.ctg.2	452	44.2	0	.	p	.	0	A251V	NONSYN	751	753	GCG	90	92	GTG	66;66;68	G;T,C;G	59;56,1;60	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	414	porB1a	984	273	91.58	porB1a.l15.c30.ctg.2	452	44.2	0	.	p	.	0	S271T	NONSYN	811	813	TCG	150	152	ACT	101;97;97	A,T;C;T,G	87,2;89;88,1	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	414	porB1a	984	273	91.58	porB1a.l15.c30.ctg.2	452	44.2	0	.	p	.	0	Y273D	NONSYN	817	819	TAT	156	158	GAT	87;86;84	G,T;A;T	78,1;77;76	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	414	porB1a	984	273	91.58	porB1a.l15.c30.ctg.2	452	44.2	0	.	p	.	0	D274S	NONSYN	820	822	GAT	159	161	AGT	84;84;85	A,G;G,A;T	76,1;74,1;74	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	414	porB1a	984	273	91.58	porB1a.l15.c30.ctg.2	452	44.2	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	168	170	TAC	86;87;87	T,A;A;C	75,1;77;74	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	414	porB1a	984	273	91.58	porB1a.l15.c30.ctg.2	452	44.2	0	.	p	.	0	R307E	NONSYN	919	921	AGA	258	260	GAA	28;28;30	G;A;A	28;28;30	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	414	porB1a	984	273	91.58	porB1a.l15.c30.ctg.2	452	44.2	0	.	p	.	0	T311A	NONSYN	931	933	ACA	270	272	GCA	27;27;26	G;C;A	26;26;24	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	414	porB1a	984	273	91.58	porB1a.l15.c30.ctg.2	452	44.2	0	.	p	.	0	E312D	NONSYN	934	936	GAA	273	275	GAC	26;26;26	G;A;C	26;25;26	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	414	porB1a	984	273	91.58	porB1a.l15.c30.ctg.2	452	44.2	0	.	p	.	0	F314I	NONSYN	940	942	TTC	279	281	ATC	25;25;25	A;T;C	25;25;25	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	414	porB1a	984	273	91.58	porB1a.l15.c30.ctg.2	452	44.2	0	.	p	.	0	A316S	NONSYN	946	948	GCG	285	287	TCG	24;24;23	T;C;G	23;24;23	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	414	porB1a	984	273	91.58	porB1a.l15.c30.ctg.2	452	44.2	0	.	p	.	0	V318A	NONSYN	952	954	GTC	291	293	GCC	23;23;23	G;C;C	21;22;22	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	414	porB1a	984	273	91.58	porB1a.l15.c30.ctg.2	452	44.2	0	.	p	.	0	G319S	NONSYN	955	957	GGC	294	296	AGC	22;21;21	A;G;C	19;21;20	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	414	porB1a	984	273	91.58	porB1a.l15.c30.ctg.2	452	44.2	0	.	p	.	0	G320A	NONSYN	958	960	GGT	297	299	GCC	20;20;20	G;C;C	18;19;20	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	414	porB1a	984	273	91.58	porB1a.l15.c30.ctg.2	452	44.2	0	.	p	.	0	G322V	NONSYN	964	966	GGT	303	305	GTT	19;18;18	G;T;T	19;18;18	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2526	porB1b	1038	1038	96.37	porB1b.l15.c4.ctg.1	1599	156.8	0	.	p	.	0	I45V	NONSYN	133	135	ATT	382	384	GTT	234;236;235	G;T;T	215;214;215	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2526	porB1b	1038	1038	96.37	porB1b.l15.c4.ctg.1	1599	156.8	0	.	p	.	0	N121S	NONSYN	361	363	AAC	610	612	AGC	158;159;161	A;G;C	145;143;147	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2526	porB1b	1038	1038	96.37	porB1b.l15.c4.ctg.1	1599	156.8	0	.	p	.	0	N122K	NONSYN	364	366	AAC	613	615	AAA	162;165;169	A;A;A	150;152;157	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2526	porB1b	1038	1038	96.37	porB1b.l15.c4.ctg.1	1599	156.8	0	.	p	.	0	F131Y	NONSYN	391	393	TTT	640	642	TAT	165;162;165	T,A;A;T	152,1;152;152	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2526	porB1b	1038	1038	96.37	porB1b.l15.c4.ctg.1	1599	156.8	0	.	p	.	0	N134E	NONSYN	400	402	AAT	649	651	GAG	164;165;163	G;A;G	152;155;151	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2526	porB1b	1038	1038	96.37	porB1b.l15.c4.ctg.1	1599	156.8	0	.	p	.	0	V135L	NONSYN	403	405	GTG	652	654	CTT	163;165;164	C;T;T	151;153;152	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2526	porB1b	1038	1038	96.37	porB1b.l15.c4.ctg.1	1599	156.8	0	.	p	.	0	G140K	NONSYN	418	420	GGA	667	669	AAA	168;168;168	A;A;A	161;161;162	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2526	porB1b	1038	1038	96.37	porB1b.l15.c4.ctg.1	1599	156.8	0	.	p	.	0	Q143E	NONSYN	427	429	CAA	676	678	GAA	176;175;172	G;A;A	167;164;165	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2526	porB1b	1038	1038	96.37	porB1b.l15.c4.ctg.1	1599	156.8	0	.	p	.	0	V151A	NONSYN	451	453	GTA	700	702	GCA	183;183;187	G;C;A	173;173;177	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2526	porB1b	1038	1038	96.37	porB1b.l15.c4.ctg.1	1599	156.8	0	.	p	.	0	K207_M208insK	INS	619	619	A	868	868	A	209	A	193	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2526	porB1b	1038	1038	96.37	porB1b.l15.c4.ctg.1	1599	156.8	0	.	p	.	0	A212S	NONSYN	634	636	GCA	886	888	TCA	206;205;203	T;C;A	191;190;187	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2526	porB1b	1038	1038	96.37	porB1b.l15.c4.ctg.1	1599	156.8	0	.	p	.	0	Y251fs	FSHIFT	751	751	T	1003	1003	T	185	T	171	.	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9646	rpoB	4179	4179	99.98	rpoB.l6.c4.ctg.1	4858	198.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1024	rpsJ	312	312	100.0	rpsJ.l15.c17.ctg.1	918	111.2	1	SNP	p	V57M	1	.	.	169	171	ATG	441	443	ATG	220;219;219	A;T;G	201;202;204	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
